Groundbreaking Real-World Multicenter Study Reveals First Evidence of Olaparib Maintenance Therapy in Newly Diagnosed Homologous Recombination Deficient Positive/BRCA Wild-Type Ovarian Cancer Patients
Ovarian cancer continues to pose significant challenges in gynecological oncology, particularly regarding its treatment and management strategies. The introduction of poly (ADP-ribose) polymerase (PARP) inhibitors...